ISRCTN82277382已完成未知
Safety and immunogenicity of concomitant administration of a virosomal hepatitis A vaccine (Epaxal®) with DTP, aHib, IPV, OPV and MMR vaccines versus non-concomitant administration in 12 to 15 month-old children
Berna Biotech Ltd (Switzerland)0 个研究点目标入组 322 人开始时间: 2006年3月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 322
研究概览
简要总结
2007 results in https://pubmed.ncbi.nlm.nih.gov/17721372/ (added 11/01/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Healthy children between 12 and 15 months old at the time of vaccination
排除标准
- •1. Children that have not received three documented doses of DTP, aHib and polio vaccines during infancy
- •2. Children that have received a documented dose of MMR during infancy
- •3. Previous vaccination against hepatitis A
- •4. Any confirmed or suspected immunosuppressive or immunodeficient condition
研究者
相似试验
进行中（未招募）
1 期
Concomitant administration of the Novavax vaccine and a 20-valent pneumococcal conjugate vaccine in adults aged =60 yearsVaccination is a key strategy for preventing respiratory illnesses. Pneumococcal vaccination is recommended for all adults (age >60 years). Given their wide application, co-administration of pneumococcal and Covid-19 vaccines may support broad population-wide coverage. However, it is unclear whether the co-administration of the new, Omicron-adapted Novavax (NVX XBB.1.5) vaccine and a 20-valent pneumococcal conjugate vaccine results in lower immunogenicity than the administration of either alone.EUCTR2022-004118-12-ATMedical University of Vienna256
进行中（未招募）
不适用
Safety and immunogenicity of concomitant vaccination with IC51 and Havrix 1440 in healthy subjects. A single-blind randomised, controlled phase 3 study.EUCTR2005-003526-25-DEIntercell AG192
已完成
1 期
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.HIV InfectionsNCT00001044National Institute of Allergy and Infectious Diseases (NIAID)80
已完成
不适用
Mixing of the COVID-19 vaccines Covishield and Covaxin for safety assessmentCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN98052401Asian Healthcare Foundation44
已完成
4 期
Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza VaccinesImmune ResponseSafetyNCT05970887Catholic Kwandong University154